News

Shares of SoFi Technologies, Inc. SOFI have declined 13.5% in the past three months compared with the industry’s 6.5% decline.

Image Source: Zacks Investment Research

This downturn raises the

DXC Technology, Inc. DXC reported better-than-expected bottom-line results for the fourth quarter of fiscal 2025. The company reported non-GAAP earnings of 84 cents per share, beating the Zacks

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust global performance in the third quarter

Jack in the Box Inc. JACK reported mixed second-quarter fiscal 2025 results, with earnings beating the Zacks Consensus Estimate and revenues missing the same. Both metrics decreased on a

UnitedHealth Group Incorporated UNH is facing a wave of challenges, with little room to catch a break. The latest blow? A criminal investigation into possible Medicare fraud was reported by the Wall

MarketAxess Holdings Inc. MKTX recently acquired a majority stake in RFQ-hub Holdings LLC, a global request-for-quote (RFQ) platform that facilitates trading in ETFs, derivatives, and structured

The Zacks Film and Television Production and Distribution industry is witnessing a surge in demand for digital entertainment due to operational constraints faced by movie theaters, theme parks and

Ross Stores (ROST) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives

The market expects StepStone Group Inc. (STEP) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

The market expects Workday (WDAY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is

Intuit (INTU) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a

Wall Street expects a year-over-year decline in earnings on higher revenues when Deckers (DECK) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Wall Street expects a year-over-year decline in earnings on higher revenues when Toronto-Dominion Bank (TD) reports results for the quarter ended April 2025. While this widely-known consensus

The market expects Advance Auto Parts (AAP) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Silvercorp (SVM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a

Autodesk (ADSK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a

The market expects Ralph Lauren (RL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

The market expects BJ's Wholesale Club (BJ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus

Toyota TM reported fiscal fourth-quarter 2025 earnings per share of $3.39, which surpassed the Zacks Consensus Estimate of $2.92 but declined from the year-ago quarter’s earnings of $4.99

Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market.  Following the

Honda HMC reported earnings of 18 cents per share for fourth-quarter fiscal 2025, missing the Zacks Consensus Estimate of 72 cents. The bottom line also declined from the year-ago profit of 99 cents

MoonLake Immunotherapeutics (MLTX) closed the last trading session at $36.99, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Shares of NovoCure (NVCR) have gained 8% over the past four weeks to close the last trading session at $17.10, but there could still be a solid upside left in the stock if short-term price targets

Arcturus Therapeutics (ARCT) closed the last trading session at $10.84, gaining 5.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Dream Finders Homes Inc. (DFH) closed the last trading session at $23.26, gaining 11.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets